Pharma IQ | 06/23/2014
The numbers of clinical trials that compare two active drugs, rather than testing a new drug against a placebo, are increasing. Comparator trials are chosen for two main reasons.
Firstly, there may be ethical reasons why using a placebo in place of a genuine treatment is not preferred. For example, if subjects have existing conditions that could worsen if their treatment is stopped for any period of time.
Secondly, there is a general increase in focus on the comparative effectiveness of...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
GenAI Life Science & Health 2025
September 1 - 3, 2025
Berlin, Germany
Register Now |
View Agenda |
Learn More
DigIT Pharma AI Commercial Excellence & Health 2025
September 1 - 3, 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More